Display options
Cite
Anker SD, Leyva F, Poole-Wilson PA, et al. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart. 1997;78(1):39-43doi: 10.1136/hrt.78.1.39.
Anker, S. D., Leyva, F., Poole-Wilson, P. A., Kox, W. J., Stevenson, J. C., & Coats, A. J. (1997). Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart (British Cardiac Society), 78(1), 39-43. https://doi.org/10.1136/hrt.78.1.39
Anker, S D, et al. "Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure." Heart (British Cardiac Society) vol. 78,1 (1997): 39-43. doi: https://doi.org/10.1136/hrt.78.1.39
Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart. 1997 Jul;78(1):39-43. doi: 10.1136/hrt.78.1.39. PMID: 9290400; PMCID: PMC484862.
Copy Download .nbib Format: NLM
Share it on
Full text links
HighWire Free PMC Article

Heart. 1997 Jul;78(1):39-43. doi: 10.1136/hrt.78.1.39.

Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.

Heart (British Cardiac Society)

S D Anker, F Leyva, P A Poole-Wilson, W J Kox, J C Stevenson, A J Coats

Affiliations

  1. Department of Cardiac Medicine, Imperial College School of Medicine, National Heart and Lung Institute, London, United Kingdom.

PMID: 9290400 PMCID: PMC484862 DOI: 10.1136/hrt.78.1.39
Free PMC Article

Abstract

OBJECTIVE: To determine whether lower limb blood flow is related to serum uric acid concentrations in patients with chronic heart failure, taking into account the hyperuricaemic effects of diuretic treatment and insulin resistance.

DESIGN: Lower limb blood flow was measured at rest and after maximum exercise followed by a five minute period of ischaemia (maximum blood flow) using strain gauge venous occlusion plethysmography. All patients underwent a metabolic assessment, which included an intravenous glucose tolerance test (IVGTT)-to obtain an index of insulin sensitivity- and measurement of serum uric acid.

SETTING: University and hospital departments specialising in cardiology and metabolic medicine.

SUBJECTS: 22 patients with chronic heart failure.

RESULTS: Mean (SEM) resting and maximum blood flow values were 2.87 (0.23) and 24.00 (1.83) ml/100 ml/min, respectively. Patients in the upper tertile of serum uric acid had lower maximum blood flow than those in the lowest tertile (15.6 (2.2) v 31.0 (2.1) ml/100 ml/min, P = 0.003). Serum uric acid correlated with maximum blood flow (r = -0.86, P < 0.001), but not with resting blood flow. In stepwise regression analysis, uric acid emerged as the only predictor of maximum blood flow (standardised coefficient = -0.83 (P < 0.001), R2 = 0.68 (P < 0.001)), independently of diuretic dose, age, body mass index, plasma creatinine, fasting and IVGTT glucose and insulin, insulin sensitivity, maximum oxygen uptake and exercise time during the treadmill exercise test, and alcohol intake.

CONCLUSIONS: There is a strong inverse relation between serum uric acid concentrations and maximum leg blood flow in patients with chronic heart failure. Further studies are needed to determine whether serum uric acid can be used as an index of vascular function in cardiovascular diseases.

Cited by

References

  1. J Clin Invest. 1968 Apr;47(4):960-70 - PubMed
  2. J Clin Pathol. 1969 Mar;22(2):158-61 - PubMed
  3. Ann Rheum Dis. 1970 Sep;29(5):461-8 - PubMed
  4. Acta Endocrinol (Copenh). 1972 Jul;70(3):487-509 - PubMed
  5. Pediatr Res. 1975 Apr;9(4):158-61 - PubMed
  6. Am J Physiol. 1979 Jun;236(6):E667-77 - PubMed
  7. Am J Cardiol. 1981 Jan;47(1):33-9 - PubMed
  8. Prog Cardiovasc Dis. 1982 May-Jun;24(6):437-59 - PubMed
  9. Br Med J (Clin Res Ed). 1986 Mar 8;292(6521):653-5 - PubMed
  10. Circulation. 1986 Aug;74(2):245-51 - PubMed
  11. Am Rev Respir Dis. 1987 Mar;135(3):534-8 - PubMed
  12. Eur J Pharmacol. 1987 Aug 11;140(2):203-7 - PubMed
  13. Diabetologia. 1987 Sep;30(9):713-8 - PubMed
  14. Proc Natl Acad Sci U S A. 1988 Jun;85(11):4046-50 - PubMed
  15. J Am Coll Cardiol. 1988 Jul;12(1):239-49 - PubMed
  16. Circulation. 1989 Oct;80(4):769-81 - PubMed
  17. J Mol Cell Cardiol. 1989 Jul;21(7):691-5 - PubMed
  18. Am J Pathol. 1990 Mar;136(3):491-5 - PubMed
  19. BMJ. 1990 Apr 14;300(6730):975-8 - PubMed
  20. J Thorac Cardiovasc Surg. 1991 Apr;101(4):713-8 - PubMed
  21. Obstet Gynecol. 1992 Mar;79(3):394-7 - PubMed
  22. JAMA. 1991 Dec 4;266(21):3008-11 - PubMed
  23. Br J Pharmacol. 1992 Mar;105(3):557-62 - PubMed
  24. Am J Physiol. 1992 Aug;263(2 Pt 2):H321-6 - PubMed
  25. Br J Pharmacol. 1993 Feb;108(2):342-7 - PubMed
  26. Circulation. 1993 Jun;87(6):1915-20 - PubMed
  27. Am Rev Respir Dis. 1993 Jul;148(1):173-8 - PubMed
  28. Cardiovasc Res. 1993 May;27(5):874-81 - PubMed
  29. Eur J Pediatr. 1993 Nov;152(11):873-6 - PubMed
  30. Circulation. 1994 Jul;90(1):291-7 - PubMed
  31. Eur Heart J. 1994 Jun;15(6):801-9 - PubMed
  32. Am J Respir Cell Mol Biol. 1994 Nov;11(5):625-30 - PubMed
  33. Free Radic Res. 1994 Sep;21(4):203-12 - PubMed
  34. Eur Heart J. 1994 Nov;15(11):1528-32 - PubMed
  35. Circulation. 1995 Dec 1;92(11):3212-9 - PubMed
  36. Anesthesiology. 1996 Jan;84(1):14-22 - PubMed
  37. Proc Soc Exp Biol Med. 1996 Apr;211(4):366-73 - PubMed
  38. Heart. 1996 May;75(5):469-76 - PubMed
  39. Eur Heart J. 1997 May;18(5):858-65 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources